NCT06172296 2026-04-14
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
National Cancer Institute (NCI)
Phase 3 Recruiting
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
Centre Oscar Lambret